IDEX (IEX) Q2 2024 earnings summary

Executive summary

• Q2 2024 sales were $807M, down 5% year-over-year and 4% organically, with adjusted EPS down 6% to $2.06 and diluted EPS up 2% to $1.86, exceeding expectations despite industrial softness and project delays.

• Gross margin improved 70 bps to 45.4% due to strong price/cost and productivity, offsetting lower volumes and higher employee costs.

• Net income was $141M, up 2%, with net income margin rising 110 bps to 17.5%.

• Free cash flow was $118M, down 2% year-over-year, with conversion rates remaining strong.

• Recent acquisitions (Mott and Subterra) and the divestiture of Alfa Valvole reflect ongoing portfolio optimization and innovation initiatives.

Financial highlights

• Q2 orders were $773M, up 2% year-over-year; net sales were $807M, down 5%; adjusted EBITDA was $224M, margin 27.8% (down 60 bps year-over-year).

• Adjusted net income was $156M; free cash flow for the quarter was $118M, with conversion rates between 75% and 88%.

• Gross margin expanded to 45.4% (up 70 bps year-over-year).

• Net income margin was 17.5% (up 110 bps year-over-year); effective tax rate was 21.2%.

• Diluted weighted average shares outstanding: 75.9M.

Outlook and guidance

• Full-year 2024 organic sales expected to decline 1%-2% (previously 0%-2% growth); adjusted EBITDA margin projected at ~27%.

• Full-year GAAP EPS guidance lowered to $6.85–$6.95 (prior $7.13–$7.43); adjusted EPS to $7.80–$7.90 (prior $8.15–$8.45).

• Q3 2024 organic sales expected to be flat to up 1% year-over-year; adjusted EPS guidance $1.85–$1.90.

• Management expects current cash, operations, and credit facility to be sufficient for foreseeable needs, including acquisitions.

• Pending $1.0B acquisition of Mott Corporation expected to close by Q3 2024.